Literature DB >> 8262149

Heparin modulates the receptor-binding and mitogenic activity of hepatocyte growth factor on hepatocytes.

D Naka1, T Ishii, T Shimomura, T Hishida, H Hara.   

Abstract

Hepatocyte growth factor (HGF) is a mitogen for hepatocytes, having high affinity for heparin. In this study, we examined the function of cell surface heparin-like molecules in HGF/receptor interaction and HGF-induced mitogenic activity using hepatocytes. Binding studies using 125I-HGF showed that more than 85% of bound HGF was released from the cell surface by washing with heparin. This procedure also released HGF from the c-Met protein, which is a component of the high-affinity receptor. In addition, heparitinase digestion of hepatocytes reduced the HGF bound to c-Met protein. Furthermore, excess heparin added during the binding of 125I-HGF to hepatocytes, significantly diminished HGF bound to c-Met protein. Moreover, when DNA synthesis of hepatocytes was repressed and retarded by excess HGF, exogenous heparin restored it. These results suggest that HGF is bound to c-Met protein and that its mitogenic activity is regulated by heparin-like molecules on hepatocytes.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8262149     DOI: 10.1006/excr.1993.1316

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  7 in total

1.  Heparin-mediated selective release of hepatocyte growth factor in humans.

Authors:  P B Salbach; M Brückmann; O Turovets; J Kreuzer; W Kübler; I Walter-Sack
Journal:  Br J Clin Pharmacol       Date:  2000-09       Impact factor: 4.335

2.  Scatter factor binds to thrombospondin and other extracellular matrix components.

Authors:  K Lamszus; A Joseph; L Jin; Y Yao; S Chowdhury; A Fuchs; P J Polverini; I D Goldberg; E M Rosen
Journal:  Am J Pathol       Date:  1996-09       Impact factor: 4.307

3.  Characterization of the enhancing effect of protamine on the proliferative activity of hepatocyte growth factor in rat hepatocytes.

Authors:  Ke-Xin Liu; Yukio Kato; Kunio Matsumoto; Toshikazu Nakamura; Taiichi Kaku; Yuichi Sugiyama
Journal:  Pharm Res       Date:  2009-01-06       Impact factor: 4.200

Review 4.  Role of hepatocyte growth factor and its receptor c-met in multiple myeloma.

Authors:  C Seidel; M Børset; H Hjorth-Hansen; A Sundan; A Waage
Journal:  Med Oncol       Date:  1998-09       Impact factor: 3.064

5.  Daily administration of low molecular weight heparin increases Hepatocyte Growth Factor serum levels in gynaecological patients: pharmacokinetic parameters and clinical implications.

Authors:  Anna Surbone; Luca Fuso; Roberto Passera; Annamaria Ferrero; Cristiana Marchese; Cosimo Martino; Annalisa Luchin; Maria Flavia Di Renzo; Paolo Zola
Journal:  BMC Res Notes       Date:  2012-09-23

6.  Increase in the circulating level of hepatocyte growth factor in gastric cancer patients.

Authors:  T Taniguchi; M Kitamura; K Arai; Y Iwasaki; Y Yamamoto; A Igari; M Toi
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

7.  Identification of core active disaccharides in heparin for HGF-inducing activity.

Authors:  Takashi Kato; Ryoichi Sakiyama; Kiyomasa Oka; Toshikazu Nakamura
Journal:  J Pharmacol Pharmacother       Date:  2015 Apr-Jun
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.